Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Profile Treatment Approach Name||JAK2 Inhibitor - ATP competitive|
|Profile Name||JAK2 rearrange|
|Drug Class||JAK2 Inhibitor - ATP competitive 15|
|PubMed Id||Reference Title||Details|
|(23630205)||Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene.||Full reference...|
|(29296813)||Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL.||Full reference...|
|(32279331)||Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.||Full reference...|
|(34376782)||Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia.||Full reference...|